Does empagliflozin modulate the autonomic nervous system among individuals with type 2 diabetes and coronary artery disease? The EMPA-HEART CardioLink-6 Holter analysis

Por Vinay Garg, Subodh Verma, Kim A. Connelly, Andrew T. Yan, Aditya Sikand, Ankit Garg, Paul Dorian, Fei Zuo, Lawrence A. Leiter, Bernard Zinman, Peter Jüni, Atul Verma, Hwee Teoh, Adrian Quan, C. David Mazer, Andrew C.T. Ha
Publicado em 2020-09-01